Wendy S. Johnson - Chief Development Officer at OnKure Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
OKUR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Wendy S. Johnson since 12/22/2023

Holdings reported by Wendy S. Johnson for OnKure Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $6.28 Jul 14, 2021 Direct

Transactions reported by Wendy S. Johnson for OnKure Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.